Hypersensitivity Reactions - USMLE Step 1

Patch testing is used to confirm allergy to nickel in patients with suspected contact dermatitis. The test site is examined 48 hours after application of a nickel-impregnated disk. The delay before reading the test is necessary because the reaction depends on which of the following processes?
Answer: Time required for cutaneous dendritic cells to present nickel–protein complexes to memory T cells and recruit macrophages When you encounter patch testing questions, think about hypersensitivity reactions and their time courses. Contact dermatitis from nickel represents a classic Type IV (delayed-type) hypersensitivity reaction, which explains why the test requires a 48-hour delay. The correct answer is (A) because nickel contact dermatitis involves a complex cellular immune response. When nickel contacts skin, it acts as a hapten, binding to skin proteins to form immunogenic complexes. Cutaneous dendritic cells (particularly Langerhans cells) must first capture and process these nickel-protein complexes, then migrate to regional lymph nodes to present antigens to T cells. Once activated, memory T cells return to the skin and recruit macrophages, creating the characteristic inflammatory response. This entire cellular cascade requires 24-48 hours to develop visibly. Choice (B) describes Type III hypersensitivity (immune complex disease), which involves antibody-antigen complexes depositing in vessels—not the mechanism in contact dermatitis. Choice (C) represents Type I hypersensitivity (immediate), involving IgE and occurring within minutes to hours, not days. Choice (D) also suggests immediate hypersensitivity with eosinophil degranulation, which doesn't match the delayed timeframe of patch testing. Study tip: Remember the "4 types, 4 timeframes" pattern: Type I (immediate/minutes), Type II (hours), Type III (hours to days), and Type IV (days). Contact dermatitis is always Type IV, requiring T-cell activation and recruitment—hence the delay in patch testing. When you see "48-72 hour delay" in immunology questions, think cellular immunity and Type IV reactions.
A 33-year-old man develops painful oral ulcers and targetoid skin lesions 2 weeks after starting lamotrigine; biopsy shows epidermal necrosis with lymphocytic infiltration. Which mechanism best describes the patient's symptoms?
Answer: Type IV: Cytotoxic T cells induce keratinocyte apoptosis, producing delayed severe mucocutaneous reactions after sensitization This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type IV hypersensitivity reaction, characterized by delayed mucocutaneous reaction like SJS from lamotrigine. Choice D is correct because it accurately describes the mechanism of a type IV hypersensitivity reaction, as supported by the vignette details including onset 2 weeks later and biopsy findings. Choice A is incorrect because it confuses type I immediate responses with delayed T-cell mediated apoptosis, which often occurs when students misinterpret reaction timing. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A 52-year-old man has hemoptysis and dyspnea; urinalysis shows RBC casts and creatinine is elevated. Anti-GBM antibodies are positive and immunofluorescence shows linear IgG. What type of hypersensitivity reaction is most likely responsible?
Answer: Type II: IgG targets basement membrane antigens, causing complement-mediated injury with linear immunofluorescence in kidney and lung This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by anti-GBM disease with linear immunofluorescence. Choice C is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including hemoptysis and positive anti-GBM antibodies. Choice A is incorrect because it confuses type III immune complexes with type II direct antibody binding, which often occurs when students misinterpret immunofluorescence patterns. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A 29-year-old man presents with hematuria and hemoptysis. Chest imaging shows bilateral alveolar infiltrates, and renal biopsy demonstrates segmental necrosis with linear immunofluorescent staining for IgG along the glomerular basement membrane. Which of the following immune mechanisms is responsible for this patient's disease?
Answer: Autoantibodies (IgG) bind type IV collagen in basement membranes, fix complement, and cause cytotoxic damage (type II hypersensitivity) When you encounter a case combining pulmonary-renal syndrome with linear immunofluorescence on kidney biopsy, think Goodpasture syndrome and hypersensitivity reaction classification. This patient's presentation is classic for Goodpasture syndrome: simultaneous lung and kidney involvement with the pathognomonic finding of linear IgG staining along the glomerular basement membrane (GBM). This linear pattern indicates antibodies directly binding to basement membrane components, specifically type IV collagen (α3 chain). These anti-GBM antibodies fix complement and recruit inflammatory cells, causing direct cytotoxic damage to both pulmonary and glomerular basement membranes. This mechanism defines type II hypersensitivity, making A correct. B describes type III hypersensitivity, which would show granular (not linear) immunofluorescence from immune complex deposition. This pattern is seen in conditions like lupus nephritis or post-infectious glomerulonephritis. C represents type I hypersensitivity (immediate allergic reactions). While mast cells and histamine can contribute to some renal diseases, this IgE-mediated mechanism doesn't explain the linear GBM staining or the chronic pulmonary-renal syndrome pattern. D describes type IV hypersensitivity (delayed-type), a T-cell mediated response causing granulomatous inflammation. This wouldn't produce the antibody-mediated linear immunofluorescence pattern characteristic of this case. Study tip: Linear immunofluorescence = direct antibody binding (type II), while granular patterns = immune complex deposition (type III). The immunofluorescence pattern is often the key distinguishing feature between these two mechanisms on USMLE questions.
A 50-year-old man develops acute kidney injury, arthralgias, and palpable purpura after chronic hepatitis B; complement levels are low. Which of the following best describes the mechanism of the patient's symptoms?
Answer: Immune complex deposition in vessels activates complement, causing vasculitis, purpura, arthralgias, and renal injury This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by immune complex-mediated vasculitis in hepatitis B with low complement. Choice C is correct because it accurately describes the mechanism of a type III hypersensitivity reaction, as supported by the vignette details including purpura and AKI. Choice D is incorrect because it confuses type IV dermatitis with systemic vasculitis, which often occurs when students misinterpret renal involvement. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
During a company picnic, a 25-year-old woman with a history of severe peanut allergy accidentally eats a cookie that contains peanut flour. Within minutes she develops generalized urticaria, bronchospasm, and hypotension. Which of the following immunologic events occurs first and is primarily responsible for initiating these acute findings?
Answer: Cross-linking of allergen-specific IgE bound to high-affinity FcεRI receptors on mast cell membranes, rapidly triggering degranulation When you encounter a question about immediate allergic reactions with symptoms like urticaria, bronchospasm, and hypotension within minutes of exposure, you're dealing with Type I hypersensitivity (anaphylaxis). The key is understanding the sequence of immunologic events and which happens first to trigger the cascade. The correct answer is A because anaphylaxis begins when peanut allergens cross-link with allergen-specific IgE antibodies that are already bound to high-affinity FcεRI receptors on mast cell and basophil surfaces. This cross-linking immediately triggers degranulation, releasing preformed mediators like histamine, tryptase, and chemotactic factors within seconds to minutes. These mediators directly cause vasodilation (hypotension), increased vascular permeability (urticaria), and smooth muscle contraction (bronchospasm). Option B describes Type II hypersensitivity involving complement activation and membrane attack complexes, which takes longer to develop and isn't the primary mechanism in food allergies. Option C represents Type III hypersensitivity with immune complex deposition and neutrophil recruitment, which typically occurs hours to days after exposure and involves different antibody classes. Option D describes Type IV (delayed-type) hypersensitivity mediated by T-cells, which takes 24-72 hours to manifest and wouldn't explain the immediate symptoms. Remember that anaphylaxis requires prior sensitization—the patient already has circulating IgE antibodies from previous peanut exposure. For USMLE Step 1, always associate immediate reactions (minutes) with Type I hypersensitivity and mast cell degranulation, while delayed reactions point to other hypersensitivity types.
A 44-year-old woman develops fever, urticaria, arthralgias, and lymphadenopathy 8 days after starting cefaclor; C3 is low and urinalysis shows mild proteinuria. What type of hypersensitivity reaction is most likely responsible?
Answer: Type III: Immune complex deposition causing serum sickness features with hypocomplementemia and systemic symptoms This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by serum sickness from cefaclor with low C3. Choice C is correct because it accurately describes the mechanism of a type III hypersensitivity reaction, as supported by the vignette details including fever and arthralgias 8 days later. Choice D is incorrect because it confuses type IV contact dermatitis with systemic immune complex disease, which often occurs when students misinterpret complement levels. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A 19-year-old hiker develops intensely pruritic, linear vesicular lesions on his forearm 48 hours after brushing against poison ivy. Which of the following cell types is primarily responsible for the dermal inflammation seen in this condition?
Answer: Previously sensitized T lymphocytes that release cytokines and recruit macrophages (type IV hypersensitivity) When you encounter a question about delayed skin reactions to environmental allergens like poison ivy, you're dealing with hypersensitivity reactions. The 48-hour delay is your key clue to identifying the mechanism. Poison ivy dermatitis is a classic example of type IV (delayed-type) hypersensitivity. The plant's urushiol oil acts as a hapten that binds to skin proteins, creating new antigens. During initial exposure, antigen-presenting cells process these modified proteins and present them to naive T cells, creating sensitized memory T lymphocytes. Upon re-exposure, these memory T cells rapidly activate, releasing inflammatory cytokines like interferon-γ and TNF-α, which recruit and activate macrophages. This cascade creates the characteristic inflammatory response 24-72 hours after contact. Choice A correctly describes this T cell-mediated mechanism. Choice B describes type I hypersensitivity (immediate allergic reactions), which involves IgE and mast cells/basophils causing reactions within minutes, not days. Choice C represents type III hypersensitivity (immune complex disease), involving circulating antigen-antibody complexes that deposit in tissues—this doesn't match the localized, delayed nature of poison ivy reactions. Choice D describes NK cell function in immune surveillance against viral infections or tumors, which is unrelated to contact dermatitis. Remember this pattern: delayed reactions (hours to days) after topical exposure to plants, metals, or chemicals almost always indicate type IV hypersensitivity mediated by T lymphocytes. The timing distinguishes it from immediate (type I) reactions that occur within minutes.
A 32-year-old medical student undergoes screening for latent tuberculosis infection. Forty-eight hours after intradermal injection of purified protein derivative (PPD), the test site shows a 10-mm area of firm induration. Which cytokines most directly mediated the cellular response responsible for this finding?
Answer: Interleukin-2 and interferon-γ released by Th1 lymphocytes When you encounter questions about tuberculin skin tests (TST), think about delayed-type hypersensitivity reactions and the specific immune cells involved. The PPD test measures your body's cell-mediated immune response to tuberculosis antigens, which occurs through a well-defined pathway. The 10-mm induration at 48-72 hours represents a classic Type IV delayed-type hypersensitivity reaction. Here's what happens: when PPD antigens are injected, memory T cells that were previously sensitized to TB antigens become activated. These are specifically Th1 cells, which release interleukin-2 (IL-2) and interferon-γ (IFN-γ). IL-2 promotes T cell proliferation and activation, while IFN-γ activates macrophages, causing them to accumulate at the injection site. The firm induration you feel is literally a collection of activated immune cells creating localized inflammation. Choice A correctly identifies this Th1-mediated response. Choice B describes Th2 responses, which involve IL-4 and IL-5 and are associated with allergic reactions and parasitic infections, not TB immunity. Choice C represents regulatory T cell function (IL-10 and TGF-β), which actually suppresses immune responses rather than creating the inflammation seen in PPD tests. Choice D describes immediate hypersensitivity (Type I), where mast cells release histamine and tryptase within minutes to hours, not the delayed response seen here. Remember this pattern: delayed induration (48-72 hours) always indicates Th1-mediated immunity. This concept applies beyond TB testing to other delayed hypersensitivity reactions you'll encounter on Step 1, including contact dermatitis and organ transplant rejection.
A 17-year-old girl with atopic asthma is exposed to cat dander while visiting a friend. Within minutes she develops wheezing that persists for several hours despite initial use of a short-acting β₂-agonist. Which mediator released from mast cells is primarily responsible for the sustained bronchoconstriction observed several hours after the exposure?
Answer: Leukotriene C₄, which causes prolonged airway smooth-muscle contraction When you encounter questions about asthma exacerbations, think about the biphasic nature of allergic reactions: immediate symptoms from preformed mediators, followed by sustained inflammation from newly synthesized mediators. This patient's prolonged bronchoconstriction hours after cat dander exposure represents the late-phase asthmatic response. While initial wheezing comes from preformed mediators like histamine (which β₂-agonists effectively counter), the sustained symptoms result from leukotrienes synthesized by mast cells through the arachidonic acid pathway. Leukotriene C₄ (LTC₄) is the key culprit here—it's 1000 times more potent than histamine at causing bronchoconstriction and produces prolonged airway smooth muscle contraction that's resistant to β₂-agonists. This explains why her wheezing persisted despite using her rescue inhaler. Looking at the wrong answers: (B) Complement fragment C5a does attract neutrophils, but it's not a primary mast cell product in allergic asthma, and neutrophils aren't the main players in this type of reaction. (C) Prostacyclin (PGI₂) actually opposes bronchoconstriction—it causes vasodilation and bronchodilation, so it wouldn't explain sustained wheezing. (D) Interferon-α is an antiviral cytokine unrelated to allergic reactions and isn't released by mast cells. Remember this pattern: immediate asthma symptoms respond well to β₂-agonists, but leukotriene-mediated late-phase reactions often require anti-inflammatory treatment like corticosteroids or leukotriene receptor antagonists (like montelukast). This is why some asthmatic patients need controller medications beyond rescue inhalers.
A 60-year-old farmer presents with progressive shortness of breath and dry cough. He reports that symptoms worsen several hours after working in his moldy barn and improve on weekends away from the farm. Chest CT shows patchy, nodular interstitial infiltrates. Precipitating antibodies against thermophilic actinomycetes are detected in serum. Which pattern best describes the immunopathogenesis of this patient's lung disease?
Answer: Initial immune complex–mediated injury followed by T-cell–driven delayed inflammation, representing a combined type III and type IV hypersensitivity reaction When you encounter a patient with respiratory symptoms that worsen hours after antigen exposure and improve with avoidance, think hypersensitivity pneumonitis (farmer's lung). This condition involves a complex immune response to inhaled organic antigens like thermophilic actinomycetes found in moldy hay. The correct answer is A because hypersensitivity pneumonitis demonstrates a biphasic immune response. Initially, inhaled antigens form immune complexes that deposit in alveolar walls, triggering complement activation and neutrophil recruitment (type III hypersensitivity). This explains the 4-6 hour delay in symptom onset. Subsequently, sensitized T-cells recognize the antigen and orchestrate chronic granulomatous inflammation (type IV hypersensitivity), leading to the progressive fibrotic changes seen on CT. Option B is wrong because type I reactions cause immediate symptoms (within minutes), not the delayed onset described here. While some patients may have immediate symptoms, the predominant pathophysiology involves types III and IV. Option C describes Goodpasture syndrome, where autoantibodies target basement membranes. This patient has precipitating antibodies against external antigens, not autoantibodies. Option D misses the immunologic basis entirely. The presence of precipitating antibodies and the pattern of exposure-related symptoms clearly indicate an immune-mediated process, not simple toxic injury. Remember: Hypersensitivity pneumonitis always involves delayed symptoms (hours after exposure) and combines immune complex formation with T-cell-mediated inflammation. The temporal pattern and precipitating antibodies are key diagnostic clues that point to this dual mechanism.
A 4-year-old girl develops petechiae and purpura one week after an uncomplicated upper respiratory tract infection. Laboratory evaluation shows platelet count of 15 × $10^9$ /L, normal hemoglobin, and normal white blood cell count. Direct antiglobulin testing of platelets is positive for IgG. Which of the following best explains the mechanism leading to thrombocytopenia in this patient?
Answer: IgG autoantibodies coat platelets, leading to Fc receptor–mediated phagocytosis by splenic macrophages (type II hypersensitivity) When you encounter a pediatric patient with sudden-onset bleeding symptoms after a viral infection, think immediately about immune thrombocytopenic purpura (ITP). This condition exemplifies how molecular mimicry can trigger autoimmune responses, making it a high-yield topic for understanding hypersensitivity mechanisms. This patient's presentation is classic for acute ITP: a previously healthy child develops petechiae and purpura about 1-2 weeks post-viral illness, with isolated severe thrombocytopenia and positive platelet-bound IgG. The mechanism involves molecular mimicry where viral antigens share structural similarities with platelet surface glycoproteins (like GPIIb/IIIa). This triggers production of cross-reactive IgG antibodies that bind to platelets, marking them for destruction. Choice A correctly describes this type II hypersensitivity reaction. IgG-coated platelets are recognized by Fc receptors on splenic macrophages, leading to rapid platelet clearance and severe thrombocytopenia. Choice B describes type III hypersensitivity with immune complex deposition, which occurs in conditions like Henoch-Schönlein purpura but doesn't explain the isolated thrombocytopenia or positive direct platelet antibody test seen here. Choice C involves type I hypersensitivity and IgE-mediated degranulation, which is not the mechanism in ITP and wouldn't cause the sustained thrombocytopenia observed. Choice D suggests type IV cell-mediated immunity targeting megakaryocytes, but bone marrow examination in ITP typically shows normal or increased megakaryocytes, indicating peripheral destruction rather than impaired production. Remember: Post-viral thrombocytopenia in children with positive platelet antibodies = ITP via molecular mimicry and type II hypersensitivity.
A 62-year-old man develops anemia and mild jaundice after 2 weeks of ceftriaxone; labs show elevated indirect bilirubin and a positive direct Coombs test. What type of hypersensitivity reaction is most likely responsible?
Answer: Type II: Antibody-mediated destruction of RBCs triggered by drug exposure, producing Coombs-positive hemolytic anemia This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced hemolytic anemia from ceftriaxone with positive Coombs. Choice B is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including anemia after 2 weeks. Choice E is incorrect because it confuses nonimmune hemolysis with antibody-mediated destruction, which often occurs when students misinterpret Coombs positivity. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A 48-year-old woman with known SLE has new joint pain and foamy urine; urinalysis shows protein 3+ and RBC casts, and C3/C4 are low. What type of hypersensitivity reaction is most likely responsible?
Answer: Type III: Immune complex deposition activates complement, leading to inflammation in joints and kidneys with low complement levels This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by immune complex deposition in SLE leading to low complement and renal involvement. Choice D is correct because it accurately describes the mechanism of a type III hypersensitivity reaction, as supported by the vignette details including proteinuria and low C3/C4. Choice B is incorrect because it confuses type II antibody-mediated injury with immune complex disease, which often occurs when students misinterpret immunofluorescence patterns. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A research volunteer receives an intradermal booster injection of tetanus toxoid for study purposes. Six hours later a 2-cm indurated, erythematous lesion with central necrosis appears at the injection site. Biopsy shows neutrophils surrounding dermal vessels containing fibrinoid necrosis. Which of the following best describes the immunologic basis of this reaction?
Answer: Preexisting IgG antibodies form complexes with the injected antigen, activate complement, and induce a localized type III Arthus reaction This question tests your understanding of hypersensitivity reactions, particularly the timing and pathophysiology that distinguish each type. When you see a question describing an inflammatory reaction with specific timing, tissue changes, and prior exposure to an antigen, think systematically through the four hypersensitivity types. The key clues here point to a Type III (immune complex-mediated) reaction: the 6-hour onset, prior exposure to tetanus toxoid creating preexisting antibodies, fibrinoid necrosis of vessels, and neutrophilic infiltration. This describes a classic Arthus reaction, where preformed IgG antibodies immediately bind the injected antigen, forming immune complexes that deposit in vessel walls, activate complement, and recruit neutrophils that release enzymes causing tissue necrosis. Choice A correctly identifies this mechanism - preexisting IgG antibodies form complexes with tetanus toxoid, leading to complement activation and localized Type III reaction. Choice B describes Type I hypersensitivity, which occurs within minutes (not 6 hours) and involves IgE, mast cells, and histamine rather than neutrophils and fibrinoid necrosis. Choice C represents Type IV hypersensitivity, which takes 24-72 hours to develop and involves T-cell mediated responses rather than antibody-antigen complexes and complement. Choice D describes Type II hypersensitivity with autoantibodies against basement membrane, but this scenario involves response to an injected foreign antigen (tetanus toxoid), not autoimmunity. Remember: timing is crucial for distinguishing hypersensitivity reactions. Type III reactions typically peak at 6-8 hours and feature immune complex deposition with neutrophilic inflammation and fibrinoid necrosis.
A 46-year-old man with SLE has pleuritic chest pain and worsening edema; urinalysis shows proteinuria and RBC casts, and C3 is low. Which of the following best describes the mechanism of the patient's symptoms?
Answer: Immune complex deposition activates complement, recruiting neutrophils and causing tissue inflammation in kidneys and serosal surfaces This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by immune complex deposition in SLE with low C3 and renal involvement. Choice A is correct because it accurately describes the mechanism of a type III hypersensitivity reaction, as supported by the vignette details including proteinuria and pleuritis. Choice C is incorrect because it confuses type II hemolysis with immune complex disease, which often occurs when students misinterpret systemic vs. cell-specific injury. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A 58-year-old man develops jaundice and anemia after starting methyldopa; labs show elevated LDH, low haptoglobin, and a positive direct Coombs test. Which laboratory finding supports the diagnosis of a type II hypersensitivity reaction?
Answer: Positive direct antiglobulin test demonstrating antibodies bound to RBCs, consistent with immune-mediated hemolysis This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced hemolytic anemia with positive Coombs. Choice B is correct because it accurately describes the laboratory finding supporting a type II hypersensitivity reaction, as supported by the vignette details including jaundice and low haptoglobin. Choice C is incorrect because it confuses type III immune complexes with type II direct antibody binding, which often occurs when students misinterpret Coombs test significance. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A 30-year-old man with a history of anaphylaxis to bee stings begins allergen immunotherapy with gradually increasing doses of purified bee-venom extract. After 18 months he can tolerate a sting with only mild local swelling. Which of the following immunologic changes is most strongly associated with his clinical improvement?
Answer: Enhanced production of allergen-specific IgG4 that competes with IgE for antigen binding and blocks mast-cell activation When you encounter allergen immunotherapy questions, focus on the underlying mechanism: shifting the immune response from a harmful IgE-mediated reaction to a protective one. Allergen immunotherapy works by gradually exposing patients to increasing doses of the offending allergen. This process fundamentally changes how the immune system responds to that substance. The key mechanism is the production of blocking antibodies - specifically IgG4 - that compete with IgE antibodies for the same antigenic binding sites. When IgG4 binds to the allergen instead of IgE, mast cells and basophils aren't activated, preventing the cascade that leads to anaphylaxis. This patient's improved tolerance after 18 months reflects this protective antibody response, making choice A correct. Choice B describes the opposite of what happens - successful immunotherapy actually reduces the clinical significance of IgE, rather than promoting more IgE production. Choice C also contradicts the therapeutic goal, as expanding Th2 cells and promoting eosinophilia would worsen allergic responses, not improve them. Choice D suggests increased basophil sensitivity, which would make reactions more severe, not milder. The wrong answers all describe processes that would either maintain or worsen the allergic state rather than improve it. They represent the pathophysiology you're trying to reverse with immunotherapy. Remember this pattern: successful allergen immunotherapy questions will focus on protective IgG4 antibodies as blocking agents. If you see immunotherapy leading to clinical improvement, look for the answer choice involving IgG4 competing with IgE for antigen binding.
A 60-year-old woman develops petechiae and gingival bleeding 5 days after starting trimethoprim-sulfamethoxazole; platelets are 8,000/µL and hemoglobin is normal. What type of hypersensitivity reaction is most likely responsible?
Answer: Type II: Drug-dependent antibodies target platelets, causing immune thrombocytopenia and bleeding with severe thrombocytopenia This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced thrombocytopenia with bleeding. Choice B is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including isolated low platelets. Choice E is incorrect because it confuses nonimmune marrow suppression with antibody-mediated destruction, which often occurs when students misinterpret selective cytopenia. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.
A 47-year-old woman develops fatigue and pallor after starting a new medication; labs show hemoglobin 7.8 g/dL, reticulocytes 9%, and a positive direct Coombs test. Which of the following best describes the mechanism of the patient's symptoms?
Answer: Antibodies bind RBC surface antigens, leading to complement activation or splenic clearance and hemolytic anemia with Coombs positivity This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced hemolytic anemia with positive Coombs and high reticulocytes. Choice A is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including fatigue and low hemoglobin. Choice E is incorrect because it confuses nonimmune suppression with immune hemolysis, which often occurs when students misinterpret reticulocyte response. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Start this quiz